Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects

Heart failure (HF) with reduced ejection fraction is common following acute myocardial infarction (MI), and active medical management can have a profound impact on prognosis. Reviewing relevant clinical trials, we focus on the pharmacological management of left ventricular systolic dysfunction (LVSD...

Descripción completa

Detalles Bibliográficos
Autores principales: Abel, Alexandra A I, Clark, Andrew L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593493/
https://www.ncbi.nlm.nih.gov/pubmed/34795500
http://dx.doi.org/10.2147/IJGM.S294896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593493/
https://www.ncbi.nlm.nih.gov/pubmed/34795500
http://dx.doi.org/10.2147/IJGM.S294896

Ejemplares similares